Clinical Trial

Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn

Completed
View on ClinicalTrials.gov →
Summary
Interest in identifying low GI foods and the food factors responsible for the low GI of foods has increased. Three corn products with varying levels of refined and whole grain corn will be compared to each other and to a dextrose control. It is hypothesized that higher levels of whole grain corn present in a food will decrease the rate of absorption and result in a lower postprandial glucose levels and glycemic index, and that the whole grain ingredient manufacturing process impacts whole grain ingredient benefits.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-16.
Status change: Recruiting → Completed 2026-03-13
Trial Details
NCT Number NCT07427654
Lead Sponsor PepsiCo Global R&D
Conditions Glycemic Index, Glycemic Load
Enrollment 29 participants
Start Date 2026-01-08
Primary Completion 2026-03-12 (estimated)
Study Completion 2026-03-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-16